BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20241017T150000
DTEND;TZID=America/Vancouver:20241017T203000
DTSTAMP:20260626T063505
CREATED:20241001T223647Z
LAST-MODIFIED:20241001T223647Z
UID:31788-1729177200-1729197000@scienceinboston.com
SUMMARY:2024 Medicinal Chemistry Symposium: New Drugs on the Horizon
DESCRIPTION:October 2024 Medicinal Chemistry Symposium\nSymposium: “New Drugs on the Horizon”\nThis meeting will be hosted by Bristol Myers Squibb in Cambridge\, MA. \nRegistration is required and ends at 11:30 PM on Friday\, October 11th\, 2024. \nThursday – October 17th\, 2024 \nBristol Myers Squibb \n250 Water St\, Cambridge\, MA 02141 \n3:00 pm Welcome \nRaj Rajur\, Medicinal Chemistry Program Chair \nCreaGen\, Woburn\, MA \n3:10 pm Introductory Remarks (Moderator) \nPaul Scola \nBMS\, Cambridge\, MA \n3:15 pm – 4:00 pm Denise Grünenfelder\, Ph.D. \nBMS\, Cambridge\, MA \nTitle: “Discovery of BMS-986408: A dual inhibitor of Diacylglycerol kinases alpha and zeta for cancer therapy” \n4:00 pm – 4:45 pm Ben Milgram\, Ph.D. \nScorpion Therapeutics\, Cambridge\, MA \nTitle: “Discovery of STX-721\, a Covalent\, Potent\, and Highly Mutant-Selective EGFR Exon20 Insertion Inhibitor for the Treatment of Non-Small-Cell Lung Cancer” \n4:45 pm – 5:00 pm Break \n5:00 pm – 5:45 pm Kevin J. Filipski\, Ph.D. \nPfizer\, Cambridge\, MA \nTitle: “PF-07328948\, the first BDK inhibitor/degrader clinical candidate as a treatment for heart failure” \n5:45 pm – 6:30 pm Robin Fairhurst\, Ph.D. \nNovartis\, Basel\, CH \nTitle: “Discovery of NVP-DFF332 as an Inhibitor of the Transcription Factor Hypoxia-Inducible Factor-2ALPHA (HIF-2α)” \n7:00 pm – 8:30 pm Dinner \n \nNESACS Med Chem Organizing Committee: Mark Ashwell; Brian. Aquila; Blaise Lippa; Andrew Scholte; Peter Fuller; Michelle Lamb; Silvana Leit; Melissa Grenier-Davies; Paul Scola; Lauren Monovich; Jason Beiger; Paul Greenspan; Raj Rajur \nNESACS BOARD MEETING\nThe Board Meeting is tentatively scheduled from 4:30-5:30 PM. \nPUBLIC IS INVITED \nYOU MUST REGISTER IN ADVANCE TO ATTEND THE SYMPOSIUM. \nIf you will only attend the Symposium (3-6:30 pm)\, please select the free “meeting only” ticket. \nIf you will attend the Symposium and dinner or just the dinner\, please select a dinner plus meeting ticket. \n• Reservations should be made no later than 11:30 PM\, Friday\, October 11\, 2024.
URL:https://scienceinboston.com/event/2024-medicinal-chemistry-symposium-new-drugs-on-the-horizon/
LOCATION:Bristol Myers Squibb\, 250 Water Street\, Cambridge\, MA\, 02141\, United States
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2024/10/https___cdn.evbuc_.com_images_835549999_19943884736_1_original.jpg
END:VEVENT
END:VCALENDAR